GGrantIndex
← Leaderboards

Carmen L. Masson

University Of California, San Francisco

$6,521,534
Attributed
$9,932,146
Total exposure
6
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.3M · FY200625
$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,932,146 · 6

By mechanism

R25$4,260,701 · 1
R24$2,560,524 · 1
R01$1,717,179 · 1
R21$877,687 · 2
K01$516,055 · 1

Top collaborators

Most similar at University Of California, San Francisco

Same institution · by research overlap

Others in their field

Top investigators on “Research Personnel

Research focus

Research PersonnelClinical TrialsDesignBaseProgramsInnovationClinical ResearchStructureAddictionSiteDrug AbuseMeetingsFundingEffectivenessScientistTrainingMentorsUnited States National Institutes Of HealthResourcesMedicalCareer DevelopmentLearningEvidence Based TreatmentAward

Grant awards (30)

Enhancing Effectiveness Research on Recovery Housing for Persons Prescribed Medication for Opioid Use Disorder$639,270
R24 · FY2025 · DA
Mentoring Emerging Scientists for Careers in Substance Use Research$340,200
R25 · FY2025 · DA · contact PI
Mentoring Emerging Scientists for Careers in Substance Use Research$340,201
R25 · FY2024 · DA · contact PI
Mentoring Emerging Scientists for Careers in Substance Use Research$306,515
R25 · FY2023 · DA · contact PI
Enhancing Effectiveness Research on Recovery Housing for Persons Prescribed Medication for Opioid Use Disorder$1,921,254
R24 · FY2022 · DA
Mentoring Emerging Scientists for Careers in Substance Use Research$370,488
R25 · FY2022 · DA · contact PI
Mentoring Emerging Scientists for Careers in Substance Use Research$450,820
R25 · FY2021 · DA · contact PI
Expanding Access to Buprenorphine Treatment among Homeless Persons with Opioid Use Disorder$202,917
R21 · FY2021 · DA · contact PI
Mentoring Emerging Scientists for Careers in Substance Use Research$412,011
R25 · FY2020 · DA · contact PI
Expanding Access to Buprenorphine Treatment among Homeless Persons with Opioid Use Disorder$243,292
R21 · FY2020 · DA · contact PI
Mentoring Emerging Scientists for Careers in Substance Use Research$355,711
R25 · FY2019 · DA · contact PI
Mentoring Early-Career Scientists for Drug Abuse Research Careers$291,390
R25 · FY2018 · DA · contact PI
Mentoring Early-Career Scientists for Drug Abuse Research Careers$328,031
R25 · FY2017 · DA · contact PI
Mentoring Early-Career Scientists for Drug Abuse Research Careers$101,736
R25 · FY2017 · DA · contact PI
Mentoring Early-Career Scientists for Drug Abuse Research Careers$12,954
R25 · FY2017 · DA · contact PI
Mentoring Early-Career Scientists for Drug Abuse Research Careers$323,875
R25 · FY2016 · DA · contact PI
Digital Health Technology Use Among Methadone Maintenance Patients$184,934
R21 · FY2016 · DA · contact PI
Digital Health Technology Use Among Methadone Maintenance Patients$11,593
R21 · FY2016 · DA · contact PI
Mentoring Early-Career Scientists for Drug Abuse Research Careers$330,800
R25 · FY2015 · DA
Digital Health Technology Use Among Methadone Maintenance Patients$234,951
R21 · FY2015 · DA · contact PI
Mentoring Early-Career Scientists for Drug Abuse Research Careers$295,969
R25 · FY2014 · DA
Hepatitis Care Coordination in Methadone Treatment$373,056
R01 · FY2010 · DA · contact PI
Hepatitis Care Coordination in Methadone Treatment$328,300
R01 · FY2009 · DA · contact PI
Hepatitis Care Coordination in Methadone Treatment$331,144
R01 · FY2008 · DA · contact PI
Hepatitis Care Coordination in Methadone Treatment$350,856
R01 · FY2007 · DA · contact PI
Hepatitis Care Coordination in Methadone Treatment$333,823
R01 · FY2006 · DA · contact PI
PREVENTION OF INFECTIOUS DISEASE IN INJECTION DRUG USERS$133,912
K01 · FY2003 · DA
PREVENTION OF INFECTIOUS DISEASE IN INJECTION DRUG USERS$130,743
K01 · FY2002 · DA
PREVENTION OF INFECTIOUS DISEASE IN INJECTION DRUG USERS$127,151
K01 · FY2001 · DA
PREVENTION OF INFECTIOUS DISEASE--INJECTION DRUG USERS$124,249
K01 · FY2000 · DA